Shuttle Pharmaceuticals Holdings (SHPH) Prepaid Assets (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Prepaid Assets came in at $1.4 million in Q1 2026, up 207.3% year-on-year from $446790.0 in Q1 2025, and up 712.88% quarter-over-quarter from $168906.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Prepaid Assets (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Prepaid Assets history runs 6 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 207.3% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 207.3% increase from a year earlier, with the FY2025 full-year figure at $168906.0, down 41.91% from the prior year.
- Prepaid Assets advanced to $1.4 million in Q1 2026 per SHPH's latest filing, from $168906.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.4 million in Q1 2026 and bottomed at $6480.0 in Q2 2023.
- The 5-year median for Prepaid Assets is $168906.0 (2025), against an average of $331217.7.
- Across the five-year window, Prepaid Assets surged 3211.71% in 2022 and tumbled 60.0% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $161148.0 in 2022, then slipped by 28.96% to $114473.0 in 2023, then surged by 154.01% to $290773.0 in 2024, then sank by 41.91% to $168906.0 in 2025, then surged by 712.88% to $1.4 million in 2026.
- Per Business Quant, the three latest SHPH Prepaid Assets figures stand at $1.4 million (Q1 2026), $168906.0 (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 168,906.00 |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 374,245.00 |
| Mar 31, 2025 | 446,790.00 |
| Dec 31, 2024 | 290,773.00 |
| Sep 30, 2024 | 103,040.00 |
| Jun 30, 2024 | 139,518.00 |
| Mar 31, 2024 | 81,534.00 |
| Dec 31, 2023 | 114,473.00 |
| Sep 30, 2023 | 170,104.00 |
| Jun 30, 2023 | 6,480.00 |
| Mar 31, 2023 | 203,836.00 |
| Dec 31, 2022 | 161,148.00 |
| Sep 30, 2022 | 163,142.00 |
| Dec 31, 2021 | 4,866.00 |